Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Study period:
60 minute exposure
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Justification for type of information:
Study performed to guidelines under GLP conditions
The Potassium salt appears to be a less severe irritant to eyes than the concurrently tested Lithium salt; therefore, it is safe to consider this to be a suitable read-across model to allow classification as skin Irrit 2

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Lithium benzoate
EC Number:
209-042-6
EC Name:
Lithium benzoate
Cas Number:
553-54-8
Molecular formula:
C7H6O2.Li
IUPAC Name:
lithium benzoate
Specific details on test material used for the study:
Name Lithium benzoate
Batch no. 16B/02
Appearance white powder
Composition Lithium benzoate > 98%
Purity min. 98.0 %
Homogeneity homogeneous
Expiry date 09. Jun. 2019

In vitro test system

Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Vehicle:
unchanged (no vehicle)
Details on test system:
The tissues were wetted with 25 µL Dulbecco’s Phosphate Buffered Saline (DPBS) buffer before applying the test item
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
ca 25 mg applied and spread over surface of wetted tissue
Duration of treatment / exposure:
60 minutes
Duration of post-treatment incubation (if applicable):
23 hours at 37C
Number of replicates:
three

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Value:
ca. 14
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Other effects / acceptance of results:
Range of viablity 13.8 - 14.4 % (mean 14.1%).
Positive control 3.5 - 3.9% (mean 3.7%)

Applicant's summary and conclusion

Interpretation of results:
Category 2 (irritant) based on GHS criteria
Conclusions:
The relative absorbance values were reduced to 14.1% after the treatment. This value is below the threshold for skin irritation (50%). Therefore, the test item is considered as irritant to skin. A corrosive test was performed on lithium benzoate and it is concluded that it is not Corrosive.
Executive summary:

Data for lithium and potassium benzoate indicates that there is the same level of potential irritation and read-across is valid.

Public data for potassium benzoate concludes it is non-corrosive.

It is concluded that potassium benzoate is Skin Irrit 2, Eye Dam 1